Harbor Capital Advisors Inc. lessened its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 85.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,254 shares of the company's stock after selling 77,518 shares during the period. Harbor Capital Advisors Inc.'s holdings in Acadia Healthcare were worth $402,000 as of its most recent SEC filing.
Several other hedge funds also recently made changes to their positions in ACHC. Lindbrook Capital LLC grew its stake in Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after buying an additional 671 shares during the last quarter. UMB Bank n.a. grew its position in Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after purchasing an additional 755 shares during the last quarter. Signaturefd LLC increased its position in Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after acquiring an additional 1,004 shares during the period. Quadrant Capital Group LLC raised its stake in Acadia Healthcare by 287.1% during the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after acquiring an additional 933 shares in the last quarter. Finally, State of Wyoming acquired a new position in Acadia Healthcare during the 4th quarter worth $56,000.
Wall Street Analyst Weigh In
ACHC has been the subject of several research analyst reports. Barclays decreased their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Bank of America decreased their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a report on Friday, February 28th. KeyCorp dropped their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Royal Bank Of Canada decreased their price target on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. Finally, Stephens raised Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $47.94.
Check Out Our Latest Analysis on ACHC
Acadia Healthcare Stock Up 3.0%
Shares of ACHC traded up $0.62 during trading hours on Wednesday, reaching $21.47. The company's stock had a trading volume of 713,270 shares, compared to its average volume of 1,768,987. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.72. The firm has a market cap of $1.98 billion, a price-to-earnings ratio of 10.50, a P/E/G ratio of 3.96 and a beta of 0.94. The company has a 50 day moving average of $23.49 and a two-hundred day moving average of $32.84. Acadia Healthcare Company, Inc. has a 1-year low of $20.36 and a 1-year high of $82.41.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The company had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. During the same quarter last year, the business posted $0.84 EPS. The company's revenue for the quarter was up .3% on a year-over-year basis. As a group, research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.
Acadia Healthcare Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Read More

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.